BARBARA BISDEE: Open Payments
NPI 1326192279 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 53 payments from 6 companies in 2025. Trend: 2023 $729 · 2024 $894 · 2025 $1,087
Food & beverage: $871Education: $216
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $393 |
| Alkermes, Inc. | 15 | $303 |
| ABBVIE INC. | 17 | $166 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
Products named: LYBALVI, VRAYLAR, ARISTADA, UZEDY, AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA, INGREZZA.
Industry payments across PA — which companies pay providers there.
